Bortezomib-pinanediol

Overview

Bortezomib -pinanediol is a proteasome inhibitor and a prodrug of Bortezomib ( HY-10227 ). Bortezomib -pinanediol inhibits cell growth and can be used for study of multiple myeloma.

Application

Products | Products > Disease Areas > Cancer | Products > Disease Areas > Blood or Cardio-cerebrovascular Disease | Products > Disease Areas > Leukemia/Lymphoma/Myeloma | Products > Disease Areas > Blood Disease | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Signaling Pathways > Proteasome

Product Information

• Catalog No.: HY-125939
• CAS No.: 205393-22-2
• Molecular Formula: C29H39BN4O4
• Molecular Weight: 518.46
• Purity: 99.87%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
• Solubility: ≥ 5 mg/mL (9.64 mM); Clear solution
• Availability: In-stock

Source

Original product source